Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We just nailed down an eighth straight up day for the dow. Even the nasdaq, okay, it dipped 0. 3 and this is confounding to a lot of people who dont understand that what certain public figures say is not necessarily what they mean. It is s though the whole thing is choreographed like a netflix series, probably rated number eight on the new movies page, and although as exciting market strength is for me, actually, the latter is not so good. So, maybe you better watch it. Let me direct you to the game plan so you know exactly why i say it is a netflix drama. I really ought to get you involved wi...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of Recursion Pharmaceuticals stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total value of $421,000.00. Following the completion of the transaction, the chief executive officer now directly owns 758,738 […]

These Nvidia partner stocks stand to gain from the semiconductor's industry dominance, but they have plenty of upside of their own.

Lingotto Investment Management LLP lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 141.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,875,077 shares of the company’s stock after buying an additional 1,100,000 shares during the period. Recursion […]